Investor Webinar 10 March 2022
LCT invites investors to attend a webinar hosted by Executive Chairman, Professor Bernie Tuch, featuring a presentation from LCT Executive Chairman, Professor Bernie Tuch on the company’s activities including the third clinical trial of NTCELL in Parkinson’s disease, together with its strategy for 2022.
DATE: Thursday 10 March 2022
TIME: from 11am AEDT (1pm NZ time)
Australia +61 2 9091 7604; New Zealand +64 4 974 7212
Access code for attendees: 624-953-609
QUESTIONS: Attendees may submit questions to
the company prior to the event or during the webinar via the control panel
A recording will also be made available following the webinar via LCT’s website and social media.